ARTICLE | Company News
CardioVascular BioTherapeutics cardiovascular news
December 3, 2007 8:00 AM UTC
CVBT engaged the Bruckner Group to assist the company in finding a joint commercialization partner for CVBT-141H to treat severe coronary heart disease. The human fibroblast growth factor-1 (FGF-1) i...